Nova Eye Medical Limited

ASX:EYE Rapporto sulle azioni

Cap. di mercato: AU$55.0m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Nova Eye Medical Gestione

Gestione criteri di controllo 4/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Tom Spurling

Amministratore delegato

AU$252.6k

Compenso totale

Percentuale dello stipendio del CEO83.5%
Mandato del CEO4yrs
Proprietà del CEO0.4%
Durata media del management6.1yrs
Durata media del Consiglio di amministrazione6.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Aug 06
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Apr 18
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

Mar 26
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Jan 19
News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

Dec 27
Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Sep 03
We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Apr 17
Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

Dec 16
Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Tom Spurling rispetto agli utili di Nova Eye Medical?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023n/an/a

-AU$14m

Sep 30 2023n/an/a

-AU$15m

Jun 30 2023AU$253kAU$211k

-AU$15m

Mar 31 2023n/an/a

-AU$13m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$9m

Jun 30 2022AU$311kAU$191k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$6m

Sep 30 2021n/an/a

-AU$5m

Jun 30 2021AU$72kAU$66k

-AU$4m

Dec 31 2020n/an/a

-AU$9m

Sep 30 2020n/an/a

-AU$10m

Jun 30 2020n/an/a

-AU$10m

Dec 31 2019n/an/a

-AU$6m

Sep 30 2019n/an/a

-AU$6m

Jun 30 2019AU$328kAU$306k

-AU$7m

Mar 31 2019n/an/a

-AU$7m

Dec 31 2018n/an/a

-AU$6m

Sep 30 2018n/an/a

-AU$6m

Jun 30 2018AU$329kAU$300k

-AU$5m

Compensazione vs Mercato: Tom's total compensation ($USD169.66K) is below average for companies of similar size in the Australian market ($USD299.11K).

Compensazione vs guadagni: Tom's compensation has been consistent with company performance over the past year.


AMMINISTRATORE DELEGATO

Tom Spurling (62 yo)

4yrs

Mandato

AU$252,551

Compensazione

Mr. Thomas H. Spurling, also known as Tom, BSc (Hons), Ph D., FRACI, FTSE, AM is an Executive Director at Nova Eye Medical Limited since August 31, 2020 and serves as its Managing Director. Mr. Spurling wa...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Victor Previn
Founder & Executive Chairman23.1yrsAU$236.84kNessun dato
Thomas Spurling
MD & Executive Directorno dataAU$252.55k0.37%
A$ 202.9k
Liam Cook
Chief Financial Officerno dataNessun datoNessun dato
Keith Byrne
Vice President of Global Operationsno dataNessun datoNessun dato
Mark Flynn
Investor Relationsno dataNessun datoNessun dato
Kate Hunt
Head of Marketingno dataNessun datoNessun dato
David Lubeck
Chief Medical Officer5.8yrsNessun datoNessun dato
Joaquin Wolff
President of Ellex iTrack6.1yrsNessun datoNessun dato
Kimberley Menzies
Group Financial Controller & Global Finance Manager8.8yrsNessun datoNessun dato
Simon Jeremy Gray
Company Secretary4.2yrsNessun datoNessun dato
Don Watton
Vice President of Global Serviceno dataAU$143.97kNessun dato
Meera Verma
Advisor to the Boardno dataAU$243.97kNessun dato

6.1yrs

Durata media

66yo

Età media

Gestione esperta: EYE's management team is seasoned and experienced (6.1 years average tenure).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Victor Previn
Founder & Executive Chairman23.1yrsAU$236.84kNessun dato
Thomas Spurling
MD & Executive Director4yrsAU$252.55k0.37%
A$ 202.9k
Rahmon Coupe
Independent Director11.3yrsAU$55.16k0.59%
A$ 321.9k
Michael Southard
Non Executive Director6.1yrsAU$59.19k0.0087%
A$ 4.8k
Daniel Webb
Independent Director1.8yrsAU$36.65k0.24%
A$ 133.3k

6.1yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: EYE's board of directors are considered experienced (6.1 years average tenure).